MARASCHI, ALESSANDRA
MARASCHI, ALESSANDRA
Universita' degli Studi di MILANO
Are the determinants of steatosis Associated with chronic hepatitis C( CHC) different from those of non alcoholic fatty liver disease ( NAFLD? )
2006-01-01 E.A. Pulixi, A.L. Fracanzani, A. Maraschi, C. Bertelli, S.R. Fargion
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
2008-01-01 A.L. Fracanzani, L. Burdick, S.L. Raselli, P.S. Pedotti, L. Grigore, G. Santorelli, L.V.C. Valenti, A. Maraschi, A.L. Catapano, S.R. Fargion
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis
2008-01-01 A. L Fracanzani, A. Maraschi, L. Burdick, C. Bertelli, E. Fatta, N. Bonelli, D. Meregaglia, S. Fargion
Differential patterns of contrast-enhancement ultrasonography with SonoVue in small focal lesions arisng in cirrhosis
2006-01-01 C. Bertelli, A.L. Fracanzani, L. Burdick, A. Sangiovanni, N. Bonelli, M. Borio, A. Maraschi, G.P. Benedetti, S.R. Fargion
Hemochromatosis in Italy in the last 30 years : role of genetic and acquired factors
2010-01-01 A.L. Fracanzani, A. Piperno, L. Valenti, M. Fraquelli, S. Coletti, A. Maraschi, D. Consonni, E. Coviello, D. Conte, S. Fargion
Hemochromatosis in Italy in the last 30 years : role of genetic and acquired factors
2009-11-01 A.L. Fracanzani, A. Piperno, L. Valenti, M. Fraquelli, S. Coletti, A. Maraschi, D. Consonni, E. Coviello, D. Conte, S. Fargion
Insulin related early andothelial dysfuction in patients with non alcoholic fatty liver disease (NAFLD)
2006-01-01 L. Burdick, G. Santorelli, L. Valenti, A. Maraschi, A. Orsatti, C. Bertelli, A.L. Fracanzani, S.R. Fargion
Long-Term survival and risk of hepatocellular carcinoma occurrence in Italian patients with hereditary hemochromatosis
2008-10-01 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Long-term survival and risk of hepatocellular carcinoma occurrence in Italian patients with hereditary hemochromatosis
2008-10-01 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Progression of carotic atherosclerotic damage is related to ALT values
2008-01-01 A.L. Fracanzani, L.V.C. Valenti, L. Burdick, C. Bertelli, E. Fatta, A. Maraschi, E.A. Pulixi, S.R. Fargion
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease
2008-10-01 E.A. Pulixi, L. Burdick, L. Valenti, C. Bertelli, E. Fatta, A. Maraschi, M. Sampietro, S. Fargion, A.L. Fracanzani
Revisitation of a cohort of 482 italian patients with hereditary hemochromatosis : changes in the last three decades
2007-11-01 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Revisitation of a cohort of 482 italian patients with hereditary hemochromatosis : changes in the last three decades
2007-09-01 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study
2006-01-01 A.L. Fracanzani, L. Burdick, S. Raselli, P. Pedotti, L. Grigore, G. Santorelli, L. Valenti, A. Maraschi, A. Catapano, S.R. Fargion
Sustained virological response (SVR) to peginterferon alfa-2a (40 KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) Vs induction therapy with interferon alfa-2a (roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C
2006-01-01 A. Maraschi, M. Borzio, A. Cargnel, S.R. Fargion
Triple antiviral therapy in HCV positive patients who failed prior combination therapy
2006-09-07 S.R. Fargion, M. Borzio, A. Maraschi, A. Cargnel